Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Lazovic (Beograd, Republic of Serbia), S. Sarac (Beograd, Republic of Serbia), R. Milic (Beograd, Republic of Serbia), V. Zugic (Beograd, Republic of Serbia). Defining the role of neutrophil-to-lymphocyte ratio in COPD patients. 1018

Member's Comments

No comment yet.

Related content which might interest you: Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker? Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Systemic inflammation in exacerbated patients with chronic obstructive pulmonary disease (COPD): the role of alterations in leptin/ghrelin ratio and/or leptin/adiponectin ratio Source: Annual Congress 2007 - Biomarkers and assessment of COPD Year: 2007 Prognostic value of neutrophil-to-lymphocyte ratio in hospitalized patients with COVID-19 Source: Virtual Congress 2021 – COVID - 19 Year: 2021 Changes in neutrophil-lymphocyte and platelet-lymphocyte ratios and clinical outcomes in idiopathic pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 The role of CD4/CD8 ratio in development of chronic obstructive pulmonary disease (COPD) among smokers Source: Eur Respir J 2002; 20: Suppl. 38, 94s Year: 2002 Selected blood parameters of inflammation (circulating immune complexes, CIC, C-reactive protein, CRP, neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio) in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Neutrophil CD64 versus Neutrophil/Lymphocyte ratio (NLR) as markers predicting in-hospital outcome in acute exacerbation of COPD Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 The prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with non-small cell lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Stability of blood eosinophilia and neutrophil-to-lymphocyte ratio in COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 The role of neutrophil/lymphocyte ratio in acute exacerbations of chronic obstructive pulmonary disease COPD Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 The prognostic role of the bronchiectasis in patients with COPD Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Implications of DLCO corrected by hemoglobin concentration for lung function preoperator risk evaluation in obese and non obese stable COPD patients Source: Annual Congress 2007 - Quality, sleep and exercise - the ingredients for a perfect life! Year: 2007 Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients? Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Prognostic value of haematological markers such as neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in small cell lung cancer. Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 SP-A and CC-16 expression in COPD patient: correlation with stage of severity and possible pathogenetic role Source: Eur Respir J 2003; 22: Suppl. 45, 77s Year: 2003 Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of COPD. Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Evaluation of FVC/DLCO ratio as a predictor for pulmonary hypertension in patients with interstitial lung diseases Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Stable state fibrinogen is additive to MR-proADM as a predictor of mortality in COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients. Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019